U.S. Pharmaceuticals & Biotech Most Popular Stocks

CBD of Denver

Market Cap: US$980.9k

Engages in developing and commercializing cannabidiol (CBD) products.

RespireRx Pharmaceuticals

Market Cap: US$949.5k

Engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders.

Alternaturals

Market Cap: US$938.2k

Manufactures and distributes supplements and all-natural remedies that are alternatives to prescription drugs.

Nexien BioPharma

Market Cap: US$913.0k

Focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions in the United States.

Rimrock Gold

Market Cap: US$865.2k

Through its subsidiary, focuses on the development and marketing a line of CBD oils, creams, and hemp extracts.

Mushrooms

Market Cap: US$845.9k

Mushrooms Inc. intends to acquire and merge with small, mid-size, and development stage companies focused on the mushroom industry.

NovelStem International

Market Cap: US$843.9k

A development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy.

SQZ Biotechnologies

Market Cap: US$825.8k

A clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions.

Helix BioMedix

Market Cap: US$786.5k

Operates as a specialty dermatology and consumer products skin health company in the United States.

Pure Harvest Group

Market Cap: US$718.0k

Focuses on the acquisition and operation of licensed medical and recreational marijuana dispensaries, cultivation facilities, and production facilities.

LadRx

Market Cap: US$717.9k

A biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors in the United States.

Nutra Pharma

Market Cap: US$710.0k

A biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States.

Neutra

Market Cap: US$690.2k

Researches, develops, and provides hemp-derived products in the nutraceutical space in the United States.

Emmaus Life Sciences

Market Cap: US$677.0k

A commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally.

Scorpius Holdings

Market Cap: US$672.6k

Through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization.

Vitalibis

Market Cap: US$670.8k

Operates as a technology-based formulator of phytocannabinoid rich hemp products with cannabidiol, along with personal care and nutritional products.

Cannabis Global

Market Cap: US$656.4k

Focuses on the creating and commercialization of engineered technologies to deliver hemp extracts and cannabinoids to the human body.

Maple Leaf Green World

Market Cap: US$624.0k

Does not have significant operations.

Hepion Pharmaceuticals

Market Cap: US$615.8k

A biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC) and other chronic liver diseases in the United States.

Sybleu

Market Cap: US$583.7k

SYBLEU INC. intends to engage in the primarily in the acquisition, licensing, and development of regenerative medical applications.

Bio-Path Holdings

Market Cap: US$531.4k

Operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States.

Pharmagreen Biotech

Market Cap: US$530.9k

Operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America.

Innovation Pharmaceuticals

Market Cap: US$528.8k

A clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective.

Regen BioPharma

Market Cap: US$469.8k

Focuses on the development of regenerative medical applications in the United States.

Grapefruit USA

Market Cap: US$464.8k

Operates as a manufacturer and distributor of cannabis products in California.

Itonis

Market Cap: US$457.0k

A development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases.

NDT Pharmaceuticals

Market Cap: US$453.1k

A biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury.

TC Biopharm (Holdings)

Market Cap: US$420.6k

A clinical-stage biopharmaceutical company, develops immunotherapy products based on its allogeneic gamma delta T cell platform in the United States.

Mydecine Innovations Group

Market Cap: US$400.2k

A biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions.

Molecular Pharmacology (USA)

Market Cap: US$399.8k

Molecular Pharmacology (USA) Limited, a development stage company, develops and commercializes pain and inflammation management products primarily in Australia and the United States.

Ecofibre

Market Cap: US$366.6k

Engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia.

Access-Power

Market Cap: US$361.2k

A medical marijuana clone company, manufactures and distributes medical marijuana clone products.

Altamira Therapeutics

Market Cap: US$342.9k

Operates as a preclinical-stage biopharmaceutical company in Switzerland, Australia, the United States, and Europe.

AREV Life Sciences Global

Market Cap: US$317.6k

Operates as an early-stage life science discovery company in Canada.

Jetblack

Market Cap: US$301.1k

Does not have significant operations.

CanaQuest Medical

Market Cap: US$298.9k

Develops health products and pharmaceuticals that utilize hemps, cannabis, and algae oils.